Growth Hormone & IGF Research
Publisher: Elsevier · ISSN 1096-6374 · 34 articles
- Low IGF-1 combined with a single clonidine stimulation test as a confirmatory tool for pediatric growth hormone deficiency
- IGF-1 as a mediator in the association between body mass index and risk of liver cancer: A prospective analysis of 432,203 participants from the UK biobank
- Prevalence and clinical correlates of pre-operative glucose homeostasis in patients with acromegaly
- Circulating IGF-1 levels and 27 digestive diseases: 461,401 UK biobank prospective analysis
- Is Somatrogon different? 6-month clinical outcomes and follow-up data in Turkish children transitioned from Somatropin to Somatrogon
- Evaluation of neuroendocrine deficits following traumatic brain injury: The role of a neurorehabilitation specialist
- Altered gut microbiome and post traumatic hypopituitarism in chronic TBI: The need for recognition, evaluation and treatment
- Growth hormone deficiency following traumatic brain injury in adults: Still much of a clinical enigma
- Body proportion is not affected by sex in LARON syndrome
- Growth hormone treatment for small for gestational age children
- Growth hormone receptor blockade in cancer treatment
- Editorial Board
- Alexander von Humboldt and the little women of Loja
- Real world performance of once weekly somatrogon on naive patients with isolated growth hormone deficiency: Mind the weight gain
- Extended follow-up is crucial for diagnosing growth hormone deficiency after traumatic brain injury in children and adolescents
- Prognostic value of immediate and short-term postoperative biochemical markers for long-term remission in acromegaly: A single-center study
- Effects of switching from somatropin to somapacitan on thyroid hormone levels in adult growth hormone deficiency: A pilot study
- Dose optimization and safety of long-acting pegylated growth hormone in pubertal idiopathic short stature: A retrospective real-world group study
- Precision medicine in pediatric growth disorders: Integrating clinical phenotype, genetics, IGF-1 biology and artificial intelligence: A systematic scoping review of PubMed-indexed literature (2000–2026)
- The GH-IGF axis in growth: An overview
- Fetal growth as an integrated maternal–placental–fetal system: What evidence can explain
- Clinical characteristics and growth hormone treatment response in children with borderline versus lower peak growth hormone stimulation test responses
- Investigation of overnight growth hormone secretion patterns in the clinical diagnosis of growth hormone neurosecretory dysfunction
- Benchmarking of growth hormone therapy in Hong Kong: ten-year data from the multi-centre GROWTH study
- Endocrine therapies and hormonal dysfunction after traumatic brain injury: A scoping review
- An assessment of the global usability of quality-of-life questionnaires in children receiving recombinant growth hormone therapy
- Stanniocalcin-PAPP-A-IGFBP-IGF axis and all-cause mortality risk in aged and middle-aged adults: A systematic review
- Once-weekly somatrogon versus daily somatropin in pediatric growth hormone deficiency: A systematic review and meta-analysis
- Age-specific reference intervals for IGF-I and IGFBP 3 in Indian adult males: Analytical comparison of IDS-iSYS and Roche immunoassays (INDIIGo II)
- Growth hormone deficiency after traumatic brain injury: Current insights and the need for preclinical modeling